Roche launches antibody to identify PRAME protein expression

Create PDF

Nov. 15, 2022—Roche has launched its Anti-PRAME (EPR20330) Rabbit Monoclonal Primary Antibody to identify PRAME protein expression in tissue samples from patients who are suspected of having melanoma.

“Studies suggest that the detection of PRAME expression by immunohistochemistry complements findings from routinely used tests and enables more informed clinical decisions and improved patient outcomes,” according to a company press release. “In particularly challenging cases, the use of PRAME IHC may highlight abnormal cells expressing the PRAME protein and provide more confidence in the diagnosis of melanoma.”